ipharmaservicesMay 17Multiple Sclerosis | News | Blogs | Updates | 2023Roche reported the Phase II FENopta study of fenebrutinib in adult patients with relapsing forms of multiple sclerosis (RMC). The drug...
ipharmaservicesMay 16Medicines and Healthcare products Regulatory Agency | News | 2023 Approvals | iPharmaCenterEisai and Biogen have jointly announced the submission of a Marketing Authorization Application (MAA) for lecanemab, an investigational...
